.After bring up $213 million in 2023-- among the year's most extensive personal biotech rounds-- Vol...
.Invite to recently's Chutes & Ladders, our summary of notable leadership hirings, firings and re...
.Equity capital funding right into biopharma cheered $9.2 billion across 215 handle the 2nd fourth o...
.Bicara Rehabs and also Zenas Biopharma have actually offered new catalyst to the IPO market along w...
.Genentech is going to close its own cancer cells immunology research division, as well as system he...
.Kezar Life Sciences is dropping its unpromising phase 1 sound tumor medication as the biotech goes ...
.Even with izokibep sustaining its newfound winning streak in the center, Acelyrin is actually no mo...
.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...
.Ovid Rehab already revealed last month that it was trimming its own headcount as the firm browses a...
.Eli Lilly has opened a $700 million R&D facility in the Boston ma Port, enhancing its RNA and DN...